Drug Approval | September 09, 2021
Zydus Cadila gets US FDA approval for antidepressant tablets
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
It had an estimated market size of US $ 32 million as of June 2021
Arrow is the marketing partner in US
The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA
TLD is recommended by WHO, USAID, and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg
Fingolimod is an immunomodulating drug. It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Subscribe To Our Newsletter & Stay Updated
